A detailed history of Regent Investment Management LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Regent Investment Management LLC holds 1,705 shares of ILMN stock, worth $243,729. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,705
Previous 1,655 3.02%
Holding current value
$243,729
Previous $316,000 9.18%
% of portfolio
0.09%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

BUY
$187.24 - $242.74 $9,362 - $12,137
50 Added 3.02%
1,705 $345,000
Q3 2022

Oct 18, 2022

SELL
$177.23 - $227.44 $8,861 - $11,372
-50 Reduced 2.93%
1,655 $316,000
Q2 2022

Jul 15, 2022

SELL
$181.58 - $368.0 $2,723 - $5,520
-15 Reduced 0.87%
1,705 $314,000
Q1 2022

Apr 19, 2022

SELL
$303.87 - $423.8 $30,387 - $42,380
-100 Reduced 5.49%
1,720 $601,000
Q4 2020

Jan 27, 2021

SELL
$292.7 - $370.96 $80,492 - $102,014
-275 Reduced 13.13%
1,820 $673,000
Q4 2019

Jan 30, 2020

SELL
$288.29 - $335.49 $50,450 - $58,710
-175 Reduced 7.71%
2,095 $695,000
Q1 2019

Apr 22, 2019

SELL
$272.57 - $321.18 $215,330 - $253,732
-790 Reduced 25.82%
2,270 $705,000
Q4 2018

Jan 22, 2019

SELL
$272.46 - $366.54 $99,447 - $133,787
-365 Reduced 10.66%
3,060 $918,000
Q3 2018

Oct 22, 2018

SELL
$279.04 - $367.06 $8,371 - $11,011
-30 Reduced 0.87%
3,425 $1.26 Million
Q2 2018

Jul 16, 2018

SELL
$228.17 - $292.07 $4,563 - $5,841
-20 Reduced 0.58%
3,455 $965,000
Q1 2018

Apr 24, 2018

SELL
$209.54 - $253.91 $104,770 - $126,955
-500 Reduced 12.58%
3,475 $822,000
Q4 2017

Jan 26, 2018

SELL
$202.23 - $230.03 $2,022 - $2,300
-10 Reduced 0.25%
3,975 $868,000
Q3 2017

Oct 12, 2017

BUY
$172.3 - $213.93 $686,615 - $852,511
3,985
3,985 $794,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.